Prevalence and multidimensional impact of sarcopenia in schizophrenia: Associations with oxidative stress, functioning, and symptom severity [0.03%]
精神分裂症中的肌少症的流行率及其多维度影响：与氧化应激、功能和症状严重程度的关系
Özgü Şişman,Sinay Önen
Özgü Şişman
Objective: This study aimed to investigate the prevalence of sarcopenia in individuals with schizophrenia and examine its associations with oxidative stress, symptom severity, functioning, and quality of life. ...
Perceptual organization and its visual subcomponents in schizophrenia and schizotypy: A systematic review [0.03%]
系统综述：精神分裂症与分裂型人格的感知组织及其视觉亚组件
Roberta Cessa,Andrea Ghiani,Ezgi Cenk et al.
Roberta Cessa et al.
Perceptual organization (PO) deficits have long been considered a hallmark of schizophrenia (SZ), reflecting disruptions in the integration of visual information. This systematic review critically evaluates the behavioral evidence for PO im...
Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia [0.03%]
随机双盲住院研究：无麸质饮食能否改善精神分裂症患者的阴性症状？
Deanna L Kelly,Christopher M Lee,Gopal Vyas et al.
Deanna L Kelly et al.
Background: There are no FDA-approved treatments for negative symptoms in schizophrenia and related disorders (SRD). In an SRD subgroup with systemic and central inflammation and elevated anti-gliadin immunoglobulin G ant...
A multimodal fusion analysis of structural and functional abnormalities in acute onset treatment-resistant schizophrenia [0.03%]
治疗抵抗性急性首发精神分裂症的结构及功能异常的多模态融合分析
Peiyu Cao,Yanlin Han,Lulu Zou et al.
Peiyu Cao et al.
Background: Patients with treatment-resistant schizophrenia (TRS) experience more severe clinical symptoms, which may derive from greater structural and functional brain abnormalities compared to non-TRS. However, the neu...
Frailty and fall risk in schizophrenia: Which components drive the risk of falls? [0.03%]
精神分裂症患者的衰弱和跌倒风险：哪些因素导致跌倒风险？
Tomomi Sugisaki,Norio Sugawara,Masataka Shinozaki et al.
Tomomi Sugisaki et al.
Objectives: Frailty is increasingly recognized in schizophrenia and is linked to adverse outcomes such as fall. However, mechanisms connecting body composition to frailty and fall risk in psychiatric inpatients remain ins...
Magnetic seizure therapy preserves delayed memory and 40-Hz auditory steady-state responses compared with electroconvulsive therapy in schizophrenia [0.03%]
磁惊厥治疗与电休克治疗相比可保持精神分裂症患者的延迟记忆和40赫兹听觉稳态反应
Yawen Hong,Jiangling Jiang,Jin Li et al.
Yawen Hong et al.
Background: Electroconvulsive therapy (ECT) is effective for schizophrenia but often impairs delayed memory, whereas magnetic seizure therapy (MST) typically spares cognition. We investigated whether these modalities diff...
Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychotic disorder- A nationwide register-linkage study [0.03%]
物质所致精神病和初次发作精神病患者使用抗精神病药物及其相关因素——一项全国范围的登记关联研究
Jeyaniroshan Jeyapalan,Heidi Taipale,Antti Tanskanen et al.
Jeyaniroshan Jeyapalan et al.
Background: Antipsychotic use after first-episode psychotic disorder (FEPD) has been widely studied, but data on substance-induced psychosis (SIP) are lacking. ...
Association between negative symptoms and health-related quality of life and functional outcomes in persons with schizophrenia: A systematic review [0.03%]
精神分裂症患者负面症状与健康相关生活质量及功能结局关联的系统综述
Allyssa Chan,Andy Lu,Trisha Menon et al.
Allyssa Chan et al.
Background: Negative symptoms in schizophrenia (SCZ) are core phenomenological characteristics known to affect health-related quality of life (HRQoL) and functioning. This systematic review aims to synthesize extant liter...
Long-term efficacy, safety, and tolerability of xanomeline and trospium chloride in schizophrenia: A 52-week, open-label trial (EMERGENT-5) [0.03%]
长期疗效、安全性和耐受性：xanomeline和trospium氯化物治疗精神分裂症的开放标签试验（EMERGENT-5）
Inder Kaul,Amy Claxton,Soumya Chaturvedi et al.
Inder Kaul et al.
Background: The M1/M4 muscarinic receptor agonist xanomeline combined with the peripherally restricted pan-muscarinic receptor antagonist trospium chloride is the first approved treatment for adults with schizophrenia wit...
Predictions of different elements of everyday functional outcomes in bipolar disorder and schizophrenia: Cognition, social cognition, clinical symptoms, and mood states as predictors [0.03%]
预测双相障碍和精神分裂症日常功能结果的不同要素：认知、社会认知、临床症状和情绪状态的作用
Megan A Neff,Katherine V Raffensperger,Raeanne C Moore et al.
Megan A Neff et al.
Background: Disability is common in serious mental illnesses across employment, everyday activities, and social outcomes. Although cognition and social cognition are known to predict disability, the level of influence acr...